TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice.
TGFbeta1 has been implicated in cell cycle control and carcinogenesis. To address the exact function of TGFbeta1 in skin carcinogenesis in vivo, mice with TGFbeta1 expression targeted to keratinocytes were subjected to long-term chemical carcinogenesis treatment. TGFbeta1 showed biphasic action during multistage skin carcinogenesis, acting early as a tumor suppressor but later enhancing the malignant phenotype. The transgenics were more resistant to induction of benign skin tumors than controls, but the malignant conversion rate was vastly increased. There was also a higher incidence of spindle cell carcinomas, which expressed high levels of endogenous TGFbeta3, suggesting that TGFbeta1 elicits an epithelial-mesenchymal transition in vivo and that TGFbeta3 might be involved in maintenance of the spindle cell phenotype. The action of TGFbeta1 in enhancing malignant progression may mimic its proposed function in modulating epithelial cell plasticity during embryonic development.
Cui
W
W
Department of Medical Genetics, Glasgow University, United Kingdom.
Fowlis
D J
DJ
Bryson
S
S
Duffie
E
E
Ireland
H
H
Balmain
A
A
Akhurst
R J
RJ
D000818:Animals; D002277:Carcinoma / Q000209:etiology*; D002294:Carcinoma, Squamous Cell / Q000209:etiology; D002478:Cells, Cultured; D005260:Female; D007158:Immunologic Techniques; D016023:Integrins / Q000378:metabolism; D007633:Keratins / Q000378:metabolism; D051379:Mice; D008822:Mice, Transgenic; D010212:Papilloma / Q000503:physiopathology; D012878:Skin Neoplasms / Q000209:etiology*; D016212:Transforming Growth Factor beta / Q000502:physiology*
D016023:Integrins; D016212:Transforming Growth Factor beta; D007633:Keratins